TYRUKO (natalizumab-sztn)

**Product type:** Human Prescription Drug

**Active ingredient:** NATALIZUMAB

**Strength:** 300 mg/15mL

**Dosage form:** Injection

**Route:** Intravenous

**Labeler:** Sandoz Inc

**Marketing category:** BLA (BLA761322)

**Pharmacologic class:** Integrin Receptor Antagonist [EPC], Integrin Receptor Antagonists [MoA]